Pulse Biosciences, Inc. Announces First-In-Human Procedures

Pulse Biosciences, Inc. announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter. All patients were successfully...

Related Keywords

Prague , Praha , Hlavníesto , Czech Republic , Vivek Reddy , Bioscience Cell , Arrhythmia Services At Mount Sinai Hospital , Company Cell , Pulse Biosciences Inc , Pulse Biosciences , Cardiac Arrhythmia Services , Mount Sinai Hospital , Pet Neuzil , Map System , Pulse Bioscience , Markets ,